VitaDAO Review 2026: What the VITA Token Gives Holders, What It Does Not, and Votes That Have Nearly Stopped
VitaDAO is a decentralized autonomous organization that funds early-stage longevity research and holds the resulting equity stakes and intellectual property. Anyone can buy its VITA governance token, which carries votes on funding and the treasury; AltStreet located no contractual or published right giving holders a claim on the DAO's assets or income. VITA traded at $0.265 on October 5, 2026, down 83% in a year and 96% below its January 2025 high. One VitaDAO-associated Ethereum Safe that AltStreet priced held about $3.7 million, mostly VITA and related ecosystem and project tokens, some of which barely trade; this is not a consolidated valuation of VitaDAO's treasury. Formal Snapshot voting has fallen to five proposals in 2025 and none in 2026, though forum discussion and a monthly newsletter continue.

No platform response on record for this review. Is this your platform? Respond or claim it.
What the data actually shows - TL;DR
VitaDAO pools money to fund longevity research, mostly at universities and early-stage companies, and takes equity or intellectual property in return; its home page reports 31 projects funded and $4.7 million deployed, while its projects page lists 37 entries totaling about $4.95 million, 30 of them equity or IP investments (16 equity stakes worth $2.28 million and 14 IP-NFTs worth $2.45 million) and seven broader initiatives; the site does not reconcile the two counts. What an outside investor can buy is the VITA governance token, on decentralized exchanges on Ethereum, Base and Solana.
Read the full assessmentShow less
VITA votes on research funding and treasury decisions; AltStreet located no contractual or published right giving VITA holders a claim on the treasury, portfolio equity, IP or distributions, and none are paid. That missing link, between the science VitaDAO funds and anything a token holder is owed, matters more than the price. Its price has fallen with the rest of the decentralized-science sector: $0.265 on October 5, 2026, a $7.0 million market capitalization, down 82.9% in a year and 96% below the $7.05 high of January 3, 2025.
One VitaDAO-associated Ethereum Safe that AltStreet priced held about $3.68 million: about $1.07 million in comparatively liquid stETH and USDC (almost all of it stETH, which carries ETH price risk), and the rest in VITA ($0.48 million), BIO from the related Bio Protocol ($0.32 million), and two project tokens of research VitaDAO funded, VITARNA ($1.37 million) and VITA-FAST ($0.44 million). Those last two are marked at prices set by very thin trading: VITA-FAST traded $694 in the day AltStreet checked and the Safe holds 645,211 of its 1,000,000 tokens. Other wallets, chains and off-chain equity are not included.
Formal Snapshot activity has fallen sharply, from 50 proposals in 2023 to five in 2025 and none in 2026; the last funding vote, in September 2025, passed with 17 voters, one of whom cast 71.3% of the votes, more concentrated than usual (since 2022 the median proposal's largest voter cast 24.7%). The organization still operates (the blog published its monthly newsletter as recently as September 25, 2026), and a $500,000 loan to the company behind VITARNA has been debated on the forum since September 2025 without a vote; while it was pending, that company's chief scientist was named a VitaDAO core advisor. VitaDAO may succeed at funding science without VITA functioning like equity in that success. VitaDAO named a Swiss association, Vitality Now, as its legal steward in December 2024, but its December 2025 terms of service name no legal entity and open with template language.
VITA carries votes on research funding and the treasury; AltStreet located no contractual or published right to the DAO's assets, income or distributions, and none are paid.
VITA's price change over the year to October 5, 2026 ($0.265); 96% below its $7.05 high of January 3, 2025 (CoinGecko).
Priced value of one VitaDAO-associated Ethereum Safe on October 6, 2026, not a consolidated treasury; about 29% in stETH and USDC, the rest in VITA, BIO and project tokens.
VITA-FAST's 24-hour trading volume; the Safe holds 645,211 of its 1,000,000 tokens, marked at $0.44 million.
Snapshot proposals in 2025 and in 2026 so far, down from 50 in 2023; the last funding vote passed with 17 voters, one casting 71.3%.
Research funding VitaDAO says it has deployed across 31 projects; its '$60.0M Projects FDV' headline is a fully diluted token valuation, not capital deployed, portfolio NAV or realized value.
Market prices from CoinGecko on October 5, 2026; Safe balances from the Safe transaction service priced at CoinGecko on October 6, 2026, excluding spam tokens, other chains, other wallets and off-chain equity. Governance figures from every vote in the Snapshot space vote.vitadao.eth.
Quick Verdict
Is this platform right for you?
VitaDAO has funded real longevity research in the open, with every project and vote on the public record. The harder question is what VITA represents economically: holders govern funding and treasury decisions, but AltStreet located no stated contractual right to the equity, IP, treasury or distributions those decisions produce. The token has fallen 83% in a year and trades thinly; the Ethereum Safe AltStreet priced is dominated by token marks rather than cash, with project-token positions far larger than their observable liquidity; and formal Snapshot voting has nearly stopped since 2025.
Best for
- Supporters who want a vote in a longevity-research collective and accept that the token may be worth little.
Avoid if
- You want a claim on research returns.
- You need liquidity.
- You need audited reporting.
Top strengths
- Public, project-by-project funding record.
- On-chain holdings and votes.
- Pharma-backed raise and real research output.
Key limitations
- No stated holder claim on assets.
- Token down 83% in a year.
- Priced Safe mostly VITA and project tokens.
- Snapshot voting near-dormant.
- Template terms naming no entity.
Compare Before Deciding
Where VitaDAO fits against alternatives
Use these hooks to pressure-test whether this is the right platform, or whether a nearby alternative matches the job better.
How this compares to Aethir Review
Aethir Review
A token-based network whose holders depend on a foundation's decisions.
How this compares to Musicow Review
Musicow Review
Tradable interests in intellectual property (song royalties).
How this compares to Aethir
Aethir
A token whose holders depend on a foundation's decisions.
Quick Answers
What most investors want to know first
The highest-signal facts first: minimums, liquidity reality, K-1 timing, and whether distributions are actually part of the experience.
Liquidity
Thin: $12,570 a day for VITA; under $7,000 a day for the IP tokens.
K-1 Timing
Not applicable.
Distributions
Not applicable.
Overview
Platform Overview
A concise read on what the platform is, how the structure works, and where the practical friction shows up for real investors.
Researchers and early-stage companies apply for funding; VitaDAO's working groups assess proposals and VITA holders vote on Snapshot. Funding goes out as equity investments or as research agreements whose IP is held as an IP-NFT; some IP-NFTs are fractionalized into tradable IP tokens (VITA-FAST for the Korolchuk Lab autophagy work, VITARNA, AB4AD and others) sold to the public. VITA, the governance token, trades on decentralized exchanges on Ethereum, Base and Solana. Since December 2024 a Swiss association, Vitality Now, acts as the legal steward that signs contracts and holds the pods and holding companies on the DAO's behalf.
Its January 2023 raise of $4.1 million in tokens, reported as led by Pfizer Ventures, drew wide attention. Press coverage places it in Neuhausen am Rheinfall, Switzerland; its legal steward since December 2024 is Vitality Now, a Swiss association.
Instrument
VITA governance token (Ethereum, Base, Solana); IP tokens per project.
Holder rights
Votes on funding and treasury; no contractual or published claim on assets located; no distributions.
Price
$0.265 on October 5, 2026; -83% in a year; -96% from the $7.05 high.
Priced Safe
$3.68 million in one VitaDAO-associated Ethereum Safe (not a consolidated treasury); about 29% in stETH and USDC.
Research
31 projects, $4.7 million deployed (home page); 37 entries, about $4.95 million (projects page).
Governance
5 Snapshot proposals in 2025, none in 2026; last funding vote 17 voters; a $500K loan pending on the forum.
Visual Summary
What the priced Safe holds
One VitaDAO-associated Ethereum Safe (0xF5307a74...5Ac2) at CoinGecko prices, October 6, 2026; not a consolidated treasury; spam tokens, other wallets, other chains and off-chain equity excluded.
VITARNA (IP token)
Value
$1.37 million
Liquidity
$6,571 a day; the Safe holds about half the supply
stETH
Value
$1.06 million
Liquidity
Liquid; carries ETH price risk
VITA (own token)
Value
$0.48 million
Liquidity
$12,570 a day
VITA-FAST (IP token)
Value
$0.44 million
Liquidity
$694 a day; the Safe holds 64.5% of supply
BIO
Value
$0.32 million
Liquidity
Traded; related ecosystem token
USDC
Value
$2,177
Liquidity
Liquid
Investor Operations
The practical questions investors actually care about: when tax documents arrive, how cash distributions work, and whether capital can be exited before the underlying asset is sold.
Tax Documents
K-1 Timing
What to expect
Not applicable.
Cash Flow
Distributions
Frequency
None.
Timing
Not applicable.
Consistency
Not applicable.
Liquidity
Exit Reality
Holding period
None.
Exit options
- Sell on a decentralized exchange.
Secondary market
Thin: $12,570 a day for VITA; under $7,000 a day for the IP tokens.
Investment Structures
VITA governance token
64,298,880 total supply (57.7% unminted); voting on Snapshot; traded on decentralized exchanges; no distributions.
IP tokens
Tokens fractionalizing individual IP-NFTs (VITA-FAST, VITARNA, AB4AD and others); the priced Safe holds large shares of their supply.
Risk
Risk Structure
This is where the marketplace pitch gives way to the actual operating reality: delayed exits, limited disclosure, fee drag, and path-dependent outcomes.
Holder rights
Votes; no contractual or published claim on assets or income located.
Price
Down 83% in a year and 96% from the high.
Priced Safe
About 29% stETH and USDC; the rest VITA and related ecosystem and project tokens, some barely traded.
Governance
Five Snapshot proposals in 2025, none in 2026; a Safe signer's wallet the largest voter on 63 of 115 proposals since 2022; a $500K loan proposal pending without a vote.
Legal
Swiss Verein steward; template terms naming no entity; no filings.
No stated claim on what the DAO owns
VITA carries votes; AltStreet located no contractual or published right to the treasury, equity, IP or distributions.
Why it matters
Research successes need not reach token holders, and nothing obliges the DAO to distribute.
Mitigation / verification
Read the tokenomics and any Vitality Now documents for holder entitlements before buying.
Marks that outrun the market
About 71% of the priced Safe's value is VITA, BIO and project tokens; the Safe holds most of VITA-FAST, which trades about $694 a day.
Why it matters
The project-token positions could not plausibly be liquidated in size at their quoted marks without substantial market impact.
Mitigation / verification
Discount the project-token marks heavily, and treat stETH as ETH exposure rather than cash.
Formal votes have nearly stopped
No Snapshot proposals in 2026; the last funding vote had 17 voters, one casting 71.3%.
Why it matters
Recent participation can be extremely concentrated, and proposals such as the $500,000 VITARNA loan can sit undecided for months.
Mitigation / verification
Check the Snapshot space and forum for recent activity before buying.
A pending loan now involves an overlapping advisory role
VDP-164 would lend $500,000 interest-free to ARTAN Bio (VITARNA), repaid only from future fundraising; while it was pending, ARTAN's chief scientist became a VitaDAO core advisor. VitaDAO discloses both roles.
Why it matters
The priced Safe already holds about half of VITARNA, its largest marked position, and forum critics doubt the loan's repayment terms.
Mitigation / verification
Read the VDP-164 forum thread and any Snapshot vote before buying.
Regulatory & Legal Posture
Security Status
VITA is sold and traded as a governance token; AltStreet located no SEC filings by VitaDAO, and the terms say nothing on the site is an offer of securities. This review does not determine the token's legal status.
VitaDAO's legal steward is Vitality Now, a Swiss association (VDP-160); the terms choose Swiss law and Zurich courts.
- AltStreet located no U.S. regulatory action or litigation involving VitaDAO in the sources reviewed (October 5, 2026); non-U.S. court and regulatory records were not comprehensively searched.
- Terms of service effective December 3, 2025: no named entity; Swiss law; Zurich courts; template preamble.
- VDP-160 (December 2024): Vitality Now, a Swiss Verein, as legal steward and ultimate beneficial owner of pods and holding companies.
Disclosure Quality
Project pages and Snapshot votes are public; there is no treasury report, audit or holder-rights document.
Custody Model
The priced Safe is a 3-of-4 Gnosis multisig; tokens are held in holders' own wallets.
Regulatory Backing
None identified.
Tax Treatment
Reporting
None
Token holders receive no tax forms from VitaDAO.
Income Character
Capital gains or losses on token sales
VITA pays no income; gains or losses arise on sale.
Limitation
AltStreet is not a tax adviser.
Special Considerations
- Airdrops such as the 2025 BIO distribution may be taxable when received in some jurisdictions.
Account Suitability
Taxable
Bought and held through a self-custody crypto wallet.
Roth IRA
Not offered directly by VitaDAO; any third-party arrangement is custodian- and tax-specific.
Traditional IRA
Not offered directly by VitaDAO; any third-party arrangement is custodian- and tax-specific.
HSA
Not offered directly by VitaDAO.
Before You Invest
Get AltStreet's weekly briefing on VitaDAO and its peers
Changes to fees, liquidity and investment terms across alternative platforms, including VitaDAO, read against the filings. One email a week.
- Weekly platform research focused on tax timing and liquidity reality.
- Signals on distributions, risks, and structural tradeoffs before capital is locked up.
- Coverage of adjacent platforms so you can compare better options faster.
Get weekly platform signals
Track fee changes, liquidity updates, risk flags, and adjacent platforms before you invest.
Independent intelligence from AltStreet. No hype. No sponsor spin.
AltStreet Data Layer
What the data actually shows
VitaDAO's on-chain record makes one Safe's holdings, the token market and governance measurable.
Priced Safe mostly token marks
$3.68 million in one VitaDAO-associated Safe; about 29% in stETH and USDC.
What this means
About $1.07 million was in comparatively liquid stETH and USDC, almost all of it stETH.
IP tokens barely trade
VITA-FAST $694 and VITARNA $6,571 of 24-hour volume.
What this means
Positions this large could not plausibly be sold at the quoted marks without substantial market impact.
Voting slowdown
50 Snapshot proposals in 2023, five in 2025, none in 2026.
What this means
Formal voting has largely stopped while discussion continues on the forum.
One signer, most votes
A Safe signer's wallet was the largest voter on 63 of 115 proposals since 2022; median top-three share 60.2%.
What this means
Outcomes have often turned on a few wallets, one of them a treasury signer.
Data as of 2026-10-05 . AltStreet review evidence layer . Public-source analysis
Full datasetDecision Fit
Investor Fit
Who this works for, who it does not, and what level of patience and complexity tolerance the platform really demands.
Supporters of longevity science who want a governance voice
VITA delivers a vote and public records; treat any purchase as a stake with no stated economic claim.
Investors seeking exposure to biotech returns
AltStreet located no stated claim on the portfolio, and the token has fallen 83% in a year.
Tradeoffs
Key Tradeoffs
The attraction of pre-IPO access is real, but every benefit comes bundled with a corresponding liquidity, transparency, or pricing cost.
Access
No stated claim on assets or income.
Transparency
No consolidated treasury report; project-token marks on thin markets.
Governance
Few Snapshot proposals since 2025; some votes highly concentrated.
Avoid
Who This Is Not For
This section should be read as a filter, not an afterthought. If you need income, simplicity, or near-term access to capital, the structure is working against you.
Anyone expecting a share of research returns
AltStreet located no stated claim on the portfolio.
Investors who need liquidity
VITA trades about $12,570 a day.
Anyone who needs audited reporting
None is published.
Editorial View
AltStreet Perspective
The compressed version of the review: what matters, what marketing tends to obscure, and how we would frame the platform for a serious allocator.
Verdict
VitaDAO has built a real and unusually transparent mechanism for funding longevity science. The harder question is what VITA represents economically. Holders can govern funding and treasury decisions, but AltStreet located no stated contractual right to the equity, IP, treasury or distributions generated by those decisions, and that distinction matters more than the portfolio's headline value. The Ethereum Safe AltStreet analyzed is dominated by token marks rather than cash-like assets, with large project-token positions far bigger than their observable trading liquidity, while formal Snapshot participation has fallen sharply. VitaDAO may succeed at funding science without VITA functioning like equity in that success.
Positioning
A decentralized-science collective whose governance token, unlike an equity or fund interest, carries no stated economic claim.
The Bottom Line
A real, transparent longevity-funding DAO whose VITA token carries votes but no stated claim on the science it funds.
Action
Next Steps
If you still want to engage after reading the review, these are the practical next moves that reduce avoidable mistakes.
Read the VITA tokenomics and any Vitality Now documents to see what, if anything, holders are entitled to.
Check the Snapshot space and forum for activity since September 2025, including whether VDP-164 has gone to a vote.
Discount the project-token marks in any treasury figure, and treat stETH as ETH exposure rather than cash.
AltStreet Research Desk
About to invest in VitaDAO, or in an offering we haven't covered?
Commission an independent diligence report: the same filing-based analysis behind this review, applied to the specific investment in front of you before you wire the money.
- Built from primary sources: SEC filings, court records, capital structure, and marketing-versus-filings comparison.
- From $750; full reports from $1,495. Fixed price confirmed up front, delivery in 3-5 business days.
- Independent by design: we work for investors and accept no compensation from the companies we cover.
Want this on every new deal, not one? Deal Intelligence sends the alert the day a new offering appears on a covered platform and follows with an analyst-approved investment committee memo.
Deal Intelligence →Appendix
Sources, Disclosures, and Supporting Context
The lower section is structured like a report appendix: relationship context first, adjacent reading second, and evidence last.
Report Appendix
Disclosure
Relationship and compensation context
+
Report Appendix
Disclosure
Relationship and compensation context
Report Appendix
Related Resources
Adjacent platform comparisons, frameworks, and category links
+
Report Appendix
Related Resources
Adjacent platform comparisons, frameworks, and category links
Further Reading
Related Resources
Adjacent frameworks and reviews that help place the platform in a broader allocation or due-diligence context.
Frameworks
Similar Platform Reviews
- Aethir Review
A token-based network whose holders depend on a foundation's decisions.
- Musicow Review
Tradable interests in intellectual property (song royalties).
Report Appendix
Evidence & Methodology
20 cited passages on file; sources, scope, and how the review was assembled
+
Report Appendix
Evidence & Methodology
20 cited passages on file; sources, scope, and how the review was assembled
Evidence on file
20 supporting passages on file for VitaDAO and its offerings from 10 source documents, 20 verified by an analyst through 2026-10-05, no discrepancies flagged. Each passage records the metric it supports, the value read from the document, the page, and the verbatim text where the document has it. Terminal subscribers read the passages; open them in the terminal.
- Cited passages
- 20
- Source documents
- 10
- Analyst verified
- 20
- Discrepancies flagged
- 0
Latest analyst verification 2026-10-05; latest extraction 2026-10-06. A discrepancy is a disagreement between two sources, or between a document and a marketing claim, recorded rather than resolved silently.
ASReview Evidence
Methodology
vitadao.com scrape (64 pages); projects page tally; one VitaDAO-associated Safe priced at CoinGecko; CoinGecko market data; every vote on all 129 Snapshot proposals; EDGAR; U.S. litigation search; press.
Scope
VitaDAO; Vitality Now; the VITA, VITA-FAST and VITARNA tokens; one VitaDAO-associated Ethereum Safe (not a consolidated treasury).
Key Findings
- *Terms: 'These Terms are a general template and do not constitute legal advice.'
- *VDP-160: 'Establish Vitality Now, a Swiss Association (Verein), to represent and safeguard VitaDAO's governance model.'
- *6.9M BIO airdrop proposal: For 823,536 / Against 1,769,651.
Primary Source Pages
FAQ
Frequently Asked Questions
High-intent search questions answered directly, without making users hunt through the full review.
Is VitaDAO legit?
VitaDAO has funded real longevity research (31 projects, $4.7 million by its count) with public votes and on-chain holdings. Its VITA token, however, carries votes but no stated claim on that research, has fallen 83% in a year, and formal Snapshot voting has nearly stopped since 2025.
What do VITA holders own?
A vote on VitaDAO's funding and treasury decisions. AltStreet located no contractual or published right giving holders a claim on the treasury, equity stakes, IP or distributions, and none are paid.
How big is VitaDAO's treasury?
VitaDAO publishes no consolidated figure. One VitaDAO-associated Ethereum Safe that AltStreet priced held about $3.68 million on October 6, 2026, roughly 29% of it in stETH and USDC (almost all stETH) and the rest in VITA, BIO and project tokens, some of which barely trade. Other wallets, chains and off-chain equity are not included.
Who runs VitaDAO?
Token holders vote on Snapshot; since December 2024 a Swiss association, Vitality Now, acts as legal steward. Since 2022 the median proposal's top three voters cast 60.2% of the vote, and one Safe signer's wallet was the largest voter on 63 of 115 proposals.
Did Pfizer invest in VitaDAO?
Press reported in January 2023 that Pfizer Ventures led a $4.1 million raise in VITA tokens alongside Shine Capital, L1 Digital and others.
